CLREX Fees and Costs — Columbia Balanced Fund, Institutional 2 Class
Data updated: 2026-07-29
The net expense ratio is 0.62%: a 0.56% management fee plus 0.06% other expenses. There are no sales loads or redemption fees. In fiscal 2024 the fund paid $1.3M in broker commissions, 0.0144% of average net assets, and portfolio turnover was 171%.
CLREX Fees and Expenses
Annual operating expenses and sales charges of CLREX. Prospectus, as of August 31, 2025.
| Annual operating expenses | |
|---|---|
| Management fee | 0.56% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.06% |
| Gross expense ratio | 0.62% |
| Fee waiver | — |
| Net expense ratio | 0.62% |
| Sales charges | |
|---|---|
| Max front load | 0.00% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
CLREX Costs Over Time
On $10,000 invested in CLREX, assuming 5% a year before costs, total costs come to $400 over 5 years, cutting the return by 0.67% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.62%) | $65 | $204 | $355 |
| Trading costs (broker commissions) | $2 | $5 | $8 |
| Lost growth on money paid in costs | $0 | $10 | $37 |
| Total costs | $67 | $219 | $400 |
| Value after costs | $10,433 | $11,357 | $12,363 |
| Impact on return, per year | 0.67% | 0.67% | 0.67% |
CLREX Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2024.
- Explicit cost rate (commissions ÷ average net assets): 0.0144%
- Total broker commissions: $1.3M
- Bought from dealers (principal trades, not a cost): $29.1B
- Portfolio turnover (prospectus): 171%
- Securities lending: none during the year
CLREX Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| Morgan Stanley | $230K | 22.54% |
| Goldman Sachs | $168K | 16.42% |
| JPMorgan | $158K | 15.50% |
| Virtu Americas LLC | $131K | 12.83% |
| Wells Fargo | $88K | 8.64% |
| Barclays | $66K | 6.43% |
| UBS | $59K | 5.74% |
| RBC Capital Markets | $41K | 4.06% |
| Citi | $40K | 3.96% |
| Jefferies LLC | $40K | 3.89% |
CLREX Dealer Counterparties
Securities bought directly from dealers (principal trades).
| Broker | Amount | Share |
|---|---|---|
| Wells Fargo | $20.4B | 71.51% |
| Morgan Stanley | $4.9B | 17.12% |
| Citi | $1.4B | 4.97% |
| JPMorgan | $974.4M | 3.42% |
| Barclays | $200.9M | 0.70% |
| Goldman Sachs | $195.1M | 0.68% |
| RBC Capital Markets | $145.6M | 0.51% |
| Citadel Securities LLC | $135.1M | 0.47% |
| Cantor Fitzgerald & Co | $91.5M | 0.32% |
| Nomura Securities International Inc. | $81.9M | 0.29% |
Columbia Balanced Fund Share Classes
Net expense ratio and maximum front-end load of each share class, cheapest first.
| Ticker | Class | Net expense ratio | Front load |
|---|---|---|---|
| CBDYX | Institutional 3 Class | 0.57% | none |
| CLREX | Institutional 2 Class | 0.62% | none |
| CBABX | C000253713 | 0.66% | none |
| CBALX | Institutional Class | 0.66% | none |
| CBLAX | Class A | 0.91% | 5.75% |
| CBLRX | Class R | 1.16% | none |
| CBLCX | Class C | 1.66% | none |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.